BSE filing, NSE: VASWANI. Summary written from the filing by ALFA Finder's alert engine.
Vaswani Industries Ltd: key numbers
- Share price
- ₹40.49
- Market cap
- ₹140.1 Cr
- Revenue (annual)
- ₹467.4 Cr
- Net profit (annual)
- ₹4.24 Cr
- P/E (TTM)
- -2240.7×Sector 16.7×
- Promoter holding
- 62.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaswani Industries Ltd
All →Vaswani Industries Preferential Issue
Vaswani Industries board approved allotment of 16,45,000 equity shares at ₹60/share to seven promoter-group members, raising ₹9.87 Crore. Shares carry an 18-month lock-in.
- Value
- ₹9.87 Cr
Vaswani Industries Preferential Issue
Vaswani Industries received in-principle approval from BSE and NSE for a preferential issue of 16,45,000 shares to promoters. The minimum issue value is Rs. 9.87 Crore.
- Value
- ₹9.87 Cr
Vaswani Industries Other Announcement
Vaswani Industries Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per SEBI Regulation 31(1)(b).
Vaswani Industries Annual General Meeting
Vaswani Industries Limited held its 23rd Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business items as scheduled.
Vaswani Industries Annual Report
Vaswani Industries Limited filed its Annual Report for FY 2025-26, incorporating the notice for the 23rd Annual General Meeting.
Vaswani Industries Annual General Meeting
Vaswani Industries has scheduled its 23rd Annual General Meeting for September 30, 2026, to be conducted via video conferencing.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.